• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

各种液体活检方法在检测结直肠癌中的诊断性能:一项荟萃分析。

Diagnostic performance of various liquid biopsy methods in detecting colorectal cancer: A meta-analysis.

机构信息

Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.

West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.

出版信息

Cancer Med. 2020 Aug;9(16):5699-5707. doi: 10.1002/cam4.3276. Epub 2020 Jul 6.

DOI:10.1002/cam4.3276
PMID:32628360
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7433831/
Abstract

Liquid biopsy is a promising method in detecting colorectal cancer (CRC). However, previous meta-analyses only focused on the diagnostic performance of cell-free DNA (cfDNA). Therefore, we firstly evaluated the overall performance of all liquid biopsy methods. The pooled sensitivities, specificities, diagnostic odds ratios, and area under curve (AUC) of summary receiver operating characteristic curve for all liquid biopsy methods, exosomes, circulating tumor cells (CTCs), and cfDNA were calculated, respectively. A total of 62 articles involving 18 739 individuals were included. Fifty-one articles were about cfDNA, five articles were about CTCs, and six articles were about exosomes. The overall performance of all liquid biopsy methods had a pooled sensitivity, specificity, and AUC of 0.77 (95% confidence interval [CI] 0.76-0.78), 0.89 (95% CI 0.88-0.90), and 0.9004, respectively. The sensitivities were 0.82 (95% CI 0.79-0.85), 0.76 (95% CI 0.72-0.80), and 0.76 (95% CI 0.75-0.77) for CTCs, exosomes, and cfDNA, respectively. The specificities were 0.97 (95% CI95% CI 0.95-0.99), 0.92 (95% CI 0.89-0.94), and 0.88 (95% CI 0.87-0.89) for CTCs, exosomes, and cfDNA, respectively. The AUC were 0.9772, 0.9037, and 0.8963 for CTCs, exosomes, and cfDNA, respectively. The overall performance of all liquid biopsy methods had great diagnostic value in detecting CRC, regardless of subtypes. Among all liquid biopsy methods, CTCs showed the best diagnostic performance.

摘要

液体活检是检测结直肠癌(CRC)的一种很有前途的方法。然而,以前的荟萃分析仅集中于游离 DNA(cfDNA)的诊断性能。因此,我们首先评估了所有液体活检方法的整体性能。分别计算了所有液体活检方法、外泌体、循环肿瘤细胞(CTC)和 cfDNA 的汇总受试者工作特征曲线的敏感性、特异性、诊断优势比和曲线下面积(AUC)。共纳入 62 篇涉及 18739 人的文章。51 篇关于 cfDNA,5 篇关于 CTC,6 篇关于外泌体。所有液体活检方法的整体性能的汇总敏感性、特异性和 AUC 分别为 0.77(95%置信区间[CI]0.76-0.78)、0.89(95%CI0.88-0.90)和 0.9004。CTC、外泌体和 cfDNA 的敏感性分别为 0.82(95%CI0.79-0.85)、0.76(95%CI0.72-0.80)和 0.76(95%CI0.75-0.77)。特异性分别为 0.97(95%CI95%CI0.95-0.99)、0.92(95%CI0.89-0.94)和 0.88(95%CI0.87-0.89)。CTC、外泌体和 cfDNA 的 AUC 分别为 0.9772、0.9037 和 0.8963。所有液体活检方法在检测 CRC 方面均具有良好的诊断价值,无论亚型如何。在所有液体活检方法中,CTC 表现出最佳的诊断性能。

相似文献

1
Diagnostic performance of various liquid biopsy methods in detecting colorectal cancer: A meta-analysis.各种液体活检方法在检测结直肠癌中的诊断性能:一项荟萃分析。
Cancer Med. 2020 Aug;9(16):5699-5707. doi: 10.1002/cam4.3276. Epub 2020 Jul 6.
2
Diagnostic value of various liquid biopsy methods for pancreatic cancer: A systematic review and meta-analysis.各种液体活检方法对胰腺癌的诊断价值:一项系统评价和荟萃分析。
Medicine (Baltimore). 2020 Jan;99(3):e18581. doi: 10.1097/MD.0000000000018581.
3
The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta-analysis.循环游离 DNA 检测结直肠癌 KRAS 突变状态的诊断准确性:一项荟萃分析。
Cancer Med. 2019 Mar;8(3):1218-1231. doi: 10.1002/cam4.1989. Epub 2019 Feb 21.
4
Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes.液体活检在卵巢癌中的应用:循环 miRNA 和外泌体的潜力。
Transl Res. 2019 Mar;205:77-91. doi: 10.1016/j.trsl.2018.10.003. Epub 2018 Oct 12.
5
Value of circulating cell-free DNA analysis as a diagnostic tool for breast cancer: a meta-analysis.循环游离DNA分析作为乳腺癌诊断工具的价值:一项荟萃分析
Oncotarget. 2017 Apr 18;8(16):26625-26636. doi: 10.18632/oncotarget.15775.
6
Multiplexed DNA Methylation Analysis in Colorectal Cancer Using Liquid Biopsy and Its Diagnostic and Predictive Value.利用液体活检进行结直肠癌的多重 DNA 甲基化分析及其诊断和预测价值。
Curr Issues Mol Biol. 2021 Oct 3;43(3):1419-1435. doi: 10.3390/cimb43030100.
7
Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).液体活检和无 PCR 超灵敏检测系统在肿瘤学中的应用(综述)。
Int J Oncol. 2018 Oct;53(4):1395-1434. doi: 10.3892/ijo.2018.4516. Epub 2018 Aug 6.
8
Liquid biopsy: current technology and clinical applications.液体活检:当前技术与临床应用。
J Hematol Oncol. 2022 Sep 12;15(1):131. doi: 10.1186/s13045-022-01351-y.
9
A meta-analysis of the value of circulating tumor cells in monitoring postoperative recurrence and metastasis of colorectal cancer.循环肿瘤细胞在监测结直肠癌术后复发转移中的价值的meta 分析。
PLoS One. 2022 Sep 19;17(9):e0274282. doi: 10.1371/journal.pone.0274282. eCollection 2022.
10
Circulating HPV cDNA in the blood as a reliable biomarker for cervical cancer: A meta-analysis.循环 HPV cDNA 在血液中作为宫颈癌可靠的生物标志物:一项荟萃分析。
PLoS One. 2020 Feb 6;15(2):e0224001. doi: 10.1371/journal.pone.0224001. eCollection 2020.

引用本文的文献

1
Proteomic insights into early pancreatic ductal adenocarcinoma biology and screening.对早期胰腺导管腺癌生物学特性及筛查的蛋白质组学见解
Discov Oncol. 2025 Aug 11;16(1):1531. doi: 10.1007/s12672-025-03317-1.
2
Prognostic value of extracellular vesicles in colorectal cancer: a systematic review and meta-analysis.细胞外囊泡在结直肠癌中的预后价值:一项系统评价和荟萃分析
Clin Transl Oncol. 2025 Apr 9. doi: 10.1007/s12094-025-03915-z.
3
Potentialities and critical issues of liquid biopsy in clinical practice: An umbrella review.液体活检在临床实践中的潜力与关键问题:一项综合综述。

本文引用的文献

1
Colorectal cancer statistics, 2020.2020 年结直肠癌统计数据。
CA Cancer J Clin. 2020 May;70(3):145-164. doi: 10.3322/caac.21601. Epub 2020 Mar 5.
2
Strategies for Colorectal Cancer Screening.结直肠癌筛查策略。
Gastroenterology. 2020 Jan;158(2):418-432. doi: 10.1053/j.gastro.2019.06.043. Epub 2019 Aug 5.
3
The role of SEPT9 in screening, diagnosis, and recurrence monitoring of colorectal cancer.SEPT9 在结直肠癌的筛查、诊断和复发监测中的作用。
Transl Oncol. 2025 Feb;52:102172. doi: 10.1016/j.tranon.2024.102172. Epub 2025 Jan 15.
4
Blood-based biomarkers and novel technologies for the diagnosis of colorectal cancer and adenomas: a narrative review.用于结直肠癌和腺瘤诊断的基于血液的生物标志物和新技术:叙述性综述。
Biomark Med. 2024;18(9):493-506. doi: 10.1080/17520363.2024.2345583. Epub 2024 Jun 20.
5
Screening and identification of serum exosomal protein ZNF587B in liquid biopsy for ovarian cancer diagnosis.用于卵巢癌诊断的液体活检中血清外泌体蛋白ZNF587B的筛选与鉴定
Am J Cancer Res. 2024 Apr 15;14(4):1904-1913. doi: 10.62347/RBTM1834. eCollection 2024.
6
Integrating a microRNA signature as a liquid biopsy-based tool for the early diagnosis and prediction of potential therapeutic targets in pancreatic cancer.整合 microRNA 特征作为一种基于液体活检的工具,用于胰腺癌的早期诊断和潜在治疗靶点预测。
Br J Cancer. 2024 Jan;130(1):125-134. doi: 10.1038/s41416-023-02488-4. Epub 2023 Nov 10.
7
Ibero-American Consensus Review and Incorporation of New Biomarkers for Clinical Practice in Colorectal Cancer.伊比利亚美洲关于将新生物标志物纳入结直肠癌临床实践的共识综述
Cancers (Basel). 2023 Sep 1;15(17):4373. doi: 10.3390/cancers15174373.
8
Circulating tumor DNA sequencing of pediatric solid and brain tumor patients: An institutional feasibility study.对小儿实体瘤和脑肿瘤患者的循环肿瘤 DNA 进行测序:一项机构可行性研究。
Pediatr Hematol Oncol. 2023;40(8):719-738. doi: 10.1080/08880018.2023.2228837. Epub 2023 Jun 27.
9
Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment.胰腺癌:发病机制、筛查、诊断和治疗。
Gastroenterology. 2022 Aug;163(2):386-402.e1. doi: 10.1053/j.gastro.2022.03.056. Epub 2022 Apr 7.
10
The role of exosomes in liquid biopsy for cancer diagnosis and prognosis prediction.外泌体在液体活检用于癌症诊断和预后预测中的作用。
Int J Cancer. 2021 Jun 1;148(11):2640-2651. doi: 10.1002/ijc.33386. Epub 2020 Nov 24.
BMC Cancer. 2019 May 14;19(1):450. doi: 10.1186/s12885-019-5663-8.
4
Perception of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement of authors publishing reviews in nursing journals: a cross-sectional online survey.作者对发表在护理期刊上的系统评价和荟萃分析(PRISMA)报告的首选报告项目的感知:一项横断面在线调查。
BMJ Open. 2019 Apr 20;9(4):e026271. doi: 10.1136/bmjopen-2018-026271.
5
Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.无细胞游离 DNA 作为结直肠癌的一种基于血液的诊断生物标志物:系统评价。
J Surg Res. 2019 Apr;236:184-197. doi: 10.1016/j.jss.2018.11.029. Epub 2018 Dec 21.
6
The diagnostic accuracy of liquid exosomes for lung cancer detection: a meta-analysis.液体外泌体用于肺癌检测的诊断准确性:一项荟萃分析。
Onco Targets Ther. 2018 Dec 24;12:181-192. doi: 10.2147/OTT.S188832. eCollection 2019.
7
Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review.循环游离 DNA 与结直肠癌:系统综述。
Int J Mol Sci. 2018 Oct 26;19(11):3356. doi: 10.3390/ijms19113356.
8
The Pathological Features of Colorectal Cancer Determine the Detection Performance on Blood ctDNA.结直肠癌的病理特征决定了血液中循环肿瘤DNA(ctDNA)的检测性能。
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818791794. doi: 10.1177/1533033818791794.
9
Circulating exosomal CPNE3 as a diagnostic and prognostic biomarker for colorectal cancer.循环外泌体 CPNE3 作为结直肠癌的诊断和预后生物标志物。
J Cell Physiol. 2019 Feb;234(2):1416-1425. doi: 10.1002/jcp.26936. Epub 2018 Aug 5.
10
Latest development of liquid biopsy.液体活检的最新进展。
J Thorac Dis. 2018 Jun;10(Suppl 14):S1645-S1651. doi: 10.21037/jtd.2018.04.68.